N
603351
vs
S
Shanghai Composite
Over the past 12 months, Nanjing Well Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of +7% compared to the Shanghai Composite's +24% growth.
Stocks Performance
603351 vs Shanghai Composite
Performance Gap
603351 vs Shanghai Composite
Performance By Year
603351 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Nanjing Well Pharmaceutical Co Ltd
Glance View
Nanjing Well Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils. The company is headquartered in Nanjing, Jiangsu and currently employs 615 full-time employees. The company went IPO on 2019-01-30. Its main products include pharmaceutical auxiliary materials, synthetic lubricating base oil and pesticide additives. The firm distributes its products primarily in domestic market.